Zydus' Nesher Pharma gets USFDA nod to market influenza drug

Zydus' Nesher Pharmaceuticals has received final approval from the USFDA to market Oseltamivir powder for oral suspension, 6 mg/ml, said the company.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news